tiprankstipranks
Tanvex Biopharma Inc (TANVF)
OTHER OTC:TANVF
US Market
TANVF
Tanvex Biopharma
RESEARCH TOOLSreports

Tanvex Biopharma (TANVF) Income Statement

6 Followers

Tanvex Biopharma Income Statement

Last quarter (Q4 2022), Tanvex Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Tanvex Biopharma's net income was $-478.01M. See Tanvex Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ -19.35M$ 3.55M$ 143.00K$ 0.00$ 0.00
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -1.30B$ -1.25B$ -1.87B$ -2.04B$ -1.75B
Operating Income
$ -1.61B$ -1.60B$ -2.10B$ -2.33B$ -1.95B
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -1.64B$ -1.54B$ -2.10B$ -2.27B$ -1.89B
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
 ― ― ― ― ―
Weighted Average Shares Outstanding (Diluted)
 ― ― ― ― ―
Currency in USD

Tanvex Biopharma Earnings and Revenue History